One year survivor of metastatic renal cell carcinoma treated with pazopanib

Research output: Contribution to journalArticle

Abstract

Tyrosine kinase inhibitor (TKI) and its side effects are well known. However, these are mainly descriptive, with pictorial data lacking. Here, in we report a case of metastatic renal cell carcinoma, treated with TKI, with classic side effects; supplemented with images that demonstrate the adverse effects of the drug. In addition, we discuss and demonstrate the computed tomography changes.

Original languageEnglish
Pages (from-to)194-196
Number of pages3
JournalUrology Annals
Volume9
Issue number2
DOIs
Publication statusPublished - 1 Apr 2017
Externally publishedYes

Fingerprint

Renal Cell Carcinoma
Protein-Tyrosine Kinases
Tomography
Pharmaceutical Preparations
pazopanib

Keywords

  • Hair depigmentation
  • metastatic renal cell carcinoma
  • pazopanib
  • tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Urology

Cite this

One year survivor of metastatic renal cell carcinoma treated with pazopanib. / Fam, Xeng Inn; Ahmed, Nurzarina; Erica Yee Hing, Wong; Jasman, Mohd Hafidzul.

In: Urology Annals, Vol. 9, No. 2, 01.04.2017, p. 194-196.

Research output: Contribution to journalArticle

@article{292e9c07d61b4e2493a70f8934c36604,
title = "One year survivor of metastatic renal cell carcinoma treated with pazopanib",
abstract = "Tyrosine kinase inhibitor (TKI) and its side effects are well known. However, these are mainly descriptive, with pictorial data lacking. Here, in we report a case of metastatic renal cell carcinoma, treated with TKI, with classic side effects; supplemented with images that demonstrate the adverse effects of the drug. In addition, we discuss and demonstrate the computed tomography changes.",
keywords = "Hair depigmentation, metastatic renal cell carcinoma, pazopanib, tyrosine kinase inhibitor",
author = "Fam, {Xeng Inn} and Nurzarina Ahmed and {Erica Yee Hing}, Wong and Jasman, {Mohd Hafidzul}",
year = "2017",
month = "4",
day = "1",
doi = "10.4103/0974-7796.204178",
language = "English",
volume = "9",
pages = "194--196",
journal = "Urology Annals",
issn = "0974-7796",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

TY - JOUR

T1 - One year survivor of metastatic renal cell carcinoma treated with pazopanib

AU - Fam, Xeng Inn

AU - Ahmed, Nurzarina

AU - Erica Yee Hing, Wong

AU - Jasman, Mohd Hafidzul

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Tyrosine kinase inhibitor (TKI) and its side effects are well known. However, these are mainly descriptive, with pictorial data lacking. Here, in we report a case of metastatic renal cell carcinoma, treated with TKI, with classic side effects; supplemented with images that demonstrate the adverse effects of the drug. In addition, we discuss and demonstrate the computed tomography changes.

AB - Tyrosine kinase inhibitor (TKI) and its side effects are well known. However, these are mainly descriptive, with pictorial data lacking. Here, in we report a case of metastatic renal cell carcinoma, treated with TKI, with classic side effects; supplemented with images that demonstrate the adverse effects of the drug. In addition, we discuss and demonstrate the computed tomography changes.

KW - Hair depigmentation

KW - metastatic renal cell carcinoma

KW - pazopanib

KW - tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=85018633363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018633363&partnerID=8YFLogxK

U2 - 10.4103/0974-7796.204178

DO - 10.4103/0974-7796.204178

M3 - Article

AN - SCOPUS:85018633363

VL - 9

SP - 194

EP - 196

JO - Urology Annals

JF - Urology Annals

SN - 0974-7796

IS - 2

ER -